It has been suggested that inhibiting the HIF-1α/PFKFB3/PFK-1 axis with metformin could suppress glycolysis and impair cancer growth in hepatocellular carcinoma, but whether similar effects can be achieved in other cancers is not yet clear [126]. The gene discussed is PFKM; the disease is cancer.